The COVID-19 pandemic has highlighted the importance of cleanliness and hygiene in preventing the spread of diseases. However, many people still confuse these two terms, leading to inadequate practices. Cleanliness focuses on the physical appearance of surfaces, while hygiene is driven by practices and measures taken to maintain health and prevent disease spread, even when a surface appears clean. Understanding the factors that affect the survival of pathogens on surfaces is crucial in developing effective cleaning protocols.

Avalon SteriTech today announced the close of a US$9 million funding in Pre-Series A round. This round initiated in April this year was participated by SoftBank Robotics Group Corp., the global leader in robotics solutions as well as Cyberport Macro Fund and a few individual angel investors

In the ongoing fight against infectious diseases, disinfectants play a crucial role in preventing the spread of harmful microorganisms. To ensure that these products are effective in real-world settings, they must undergo rigorous testing against a variety of common pathogens, including bacteria, viruses, and fungi.

Avalon SteriTech specializes in infection control solutions, today announced its strategic partnership with disinfectant expert MicroSafe Group. With the goal of protecting businesses against COVID-19 and other infectious viruses in the post-pandemic era, the partnership combines the companies' strengths in delivering safe and powerful disinfection solutions through applying Nanocyn® Disinfectant & Sanitiser in tandem with AI-Powered disinfection robot Whiz Gambit.

SoftBank Robotics Group Corp. ("SBRG") today announced its strategic equity investment in Avalon SteriTech ("Avalon"), marks a great step forward in strengthening the companies' collaboration since its joint venture was established in March 2021. Upon the completion of the transaction, SBRG will own approximately 5% stake in Avalon's disinfection business.

Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robotic solution, jointly launched by SoftBank Robotics Group and Avalon SteriTech, is now available across EMEA region following its launch in Asia Pacific in March.

Avalon SteriTech and SoftBank Robotics announced a joint venture focusing on the development of innovative products and technologies that strive to empower and benefit public health and well-being